John R. Moore - 03 Jun 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
General Counsel
Signature
/s/ John R. Moore
Issuer symbol
EWTX
Transactions as of
03 Jun 2022
Net transactions value
-$225,644
Form type
4
Filing time
07 Jun 2022, 19:03:56 UTC
Previous filing
18 May 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $29,394 +15,230 +508% $1.93 18,230 03 Jun 2022 Direct F1, F2
transaction EWTX Common Stock Sale $92,198 -15,230 -84% $6.05 3,000 03 Jun 2022 Direct F3
transaction EWTX Common Stock Options Exercise $26,893 +13,934 +464% $1.93 16,934 06 Jun 2022 Direct
transaction EWTX Common Stock Sale $84,085 -13,934 -82% $6.03 3,000 06 Jun 2022 Direct F4
transaction EWTX Common Stock Options Exercise $1,878 +973 +32% $1.93 3,973 07 Jun 2022 Direct
transaction EWTX Common Stock Sale $6,427 -973 -24% $6.60 3,000 07 Jun 2022 Direct F5
transaction EWTX Common Stock Options Exercise $12,176 +17,150 +572% $0.7100* 20,150 07 Jun 2022 Direct
transaction EWTX Common Stock Sale $113,276 -17,150 -85% $6.60 3,000 07 Jun 2022 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -15,230 -6.7% $0.000000 211,828 03 Jun 2022 Common Stock 15,230 $1.93 Direct F6
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -13,934 -6.6% $0.000000 197,894 06 Jun 2022 Common Stock 13,934 $1.93 Direct F6
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -973 -0.49% $0.000000 196,921 07 Jun 2022 Common Stock 973 $1.93 Direct F6
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -17,150 -8.4% $0.000000 188,172 07 Jun 2022 Common Stock 17,150 $0.7100 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022.
F2 Includes 1,438 shares purchased on May 16, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
F3 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.91, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date.
F7 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.